Ube2utm1e(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Ube2utm1e(KOMP)Wtsi |
Name: |
ubiquitin-conjugating enzyme E2U (putative); targeted mutation 1e, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4363149 |
Gene: |
Ube2u Location: Chr4:100336064-100407342 bp, + strand Genetic Position: Chr4, 45.72 cM
|
Alliance: |
Ube2utm1e(KOMP)Wtsi page
|
IMPC: |
Ube2u gene page |
|
Mutant Cell Lines: |
EPD0036_4_A05, EPD0036_4_A06, EPD0036_4_D05, EPD0036_4_F06, EPD0036_4_G04, EPD0036_4_G05 |
Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
Parent Cell Line: |
JM8.F6 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_gt0
|
|
|
Mutation details: The L1L2_gt0 cassette was inserted at position 100346823 of Chromosome 4 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT flanked lacZ/neomycin sequence followed by a loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
3 reference(s) |
|